🇺🇸 FDA
Patent

US 7598420

Rasagiline formulations and processes for their preparation

granted A61KA61K31/135A61K9/2018

Quick answer

US patent 7598420 (Rasagiline formulations and processes for their preparation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/135, A61K9/2018, A61K9/2059